Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.400
-0.080 (-5.41%)
Jul 31, 2026, 4:00 PM EDT - Market closed
PACB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 56.27 | 63.71 | 55.37 | 179.91 | 325.09 | 460.73 |
Short-Term Investments | 219.69 | 215.8 | 334.56 | 451.51 | 447.23 | 583.68 |
Cash & Short-Term Investments | 275.96 | 279.51 | 389.93 | 631.42 | 772.32 | 1,044 |
Cash Growth | -19.57% | -28.32% | -38.25% | -18.24% | -26.05% | 227.59% |
Accounts Receivable | 29.35 | 35.45 | 27.52 | 36.62 | 18.79 | 24.24 |
Inventory | 51.02 | 49.29 | 58.76 | 56.68 | 50.38 | 24.6 |
Other Current Assets | 13.18 | 10.81 | 19.47 | 17.34 | 10.59 | 7.89 |
Total Current Assets | 369.52 | 375.05 | 495.68 | 742.05 | 852.07 | 1,101 |
Net Property, Plant & Equipment | 65.22 | 65.84 | 46.6 | 69.03 | 81.34 | 79.12 |
Other Intangible Assets | 14.1 | 15.12 | 389.57 | 456.98 | 410.25 | 410.98 |
Goodwill | 317.76 | 317.76 | 317.76 | 462.26 | 409.97 | 409.97 |
Other Long-Term Assets | 15.76 | 10.31 | 10.84 | 15.7 | 13.45 | 5.76 |
Total Assets | 782.37 | 784.08 | 1,260 | 1,746 | 1,767 | 2,007 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 13.61 | 20.77 | 16.59 | 15.06 | 12.03 | 11 |
Accrued Expenses | 33.9 | 33.65 | 22.6 | 45.71 | 32.6 | 36.26 |
Current Portion of Leases | 0.28 | 0.45 | 10.03 | 9.59 | 8.89 | 7.71 |
Unearned Revenue | 16.33 | 15.94 | 13.86 | 16.34 | 30.5 | 10.98 |
Other Current Liabilities | 1.24 | 2.03 | 3.22 | 8.33 | 179.33 | 5.76 |
Total Current Liabilities | 65.36 | 72.83 | 66.3 | 95.03 | 263.34 | 71.71 |
Long-Term Debt | 644.11 | 645.38 | 647.49 | 892.24 | 896.68 | 896.07 |
Long-Term Leases | 59 | 56.59 | 14.91 | 31.61 | 41.07 | 49.97 |
Other Long-Term Liabilities | 11.53 | 3.93 | 25.15 | 25.83 | 3.09 | 198.24 |
Total Long-Term Liabilities | 714.64 | 705.9 | 687.55 | 949.68 | 940.85 | 1,144 |
Total Liabilities | 780 | 778.73 | 753.85 | 1,045 | 1,204 | 1,216 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.31 | 0.3 | 0.29 | 0.27 | 0.23 | 0.22 |
Additional Paid-in Capital | 2,706 | 2,700 | 2,655 | 2,540 | 2,100 | 2,010 |
Accumulated Other Comprehensive Income | -0.15 | 0.46 | 0.42 | 0.22 | -4.77 | -1.09 |
Retained Earnings | -2,704 | -2,695 | -2,149 | -1,839 | -1,532 | -1,218 |
Shareholders' Equity | 2.37 | 5.35 | 506.59 | 701.3 | 562.9 | 790.99 |
Total Liabilities & Equity | 782.37 | 784.08 | 1,260 | 1,746 | 1,767 | 2,007 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 703.39 | 702.42 | 672.43 | 933.44 | 946.64 | 953.75 |
Net Cash (Debt) | -427.43 | -422.92 | -282.5 | -302.02 | -174.32 | 90.65 |
Net Cash Growth | - | - | - | - | - | -67.25% |
Net Cash Per Share | -1.41 | -1.41 | -0.98 | -1.19 | -0.78 | 0.44 |
Book Value | 2.37 | 5.35 | 506.59 | 701.3 | 562.9 | 790.99 |
Book Value Per Share | 0.01 | 0.02 | 1.76 | 2.77 | 2.51 | 3.87 |
Tangible Book Value | -329.5 | -327.54 | -200.74 | -217.94 | -257.32 | -29.97 |
Tangible Book Value Per Share | -1.09 | -1.09 | -0.70 | -0.86 | -1.15 | -0.15 |